Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
-
Mar 15, 2024 (filed on Mar 15, 2024)Insider Name:Nash MarcOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-2,391Price:$2.13
-
Mar 12, 2024 (filed on Mar 13, 2024)Insider Name:Lang Brent D.Ownership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:108,024Price:--
-
Mar 01, 2024 (filed on Mar 04, 2024)Insider Name:Ahmed NabeelOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-1,584Price:$3.15
-
Feb 29, 2024 (filed on Mar 04, 2024)Insider Name:Ahmed NabeelOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:J - Other transaction# or value acquired/disposed of:1,584Price:$2.68
-
Feb 23, 2024 (filed on Feb 26, 2024)Insider Name:Ahmed NabeelOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-10,639Price:$3.72
-
Feb 23, 2024 (filed on Feb 26, 2024)Insider Name:Ahmed NabeelOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:20,922Price:--
-
Feb 23, 2024 (filed on Feb 26, 2024)Insider Name:Trigg LeslieOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-45,538Price:$3.72
-
Feb 23, 2024 (filed on Feb 26, 2024)Insider Name:Trigg LeslieOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:131,687Price:--
-
Feb 15, 2024 (filed on Feb 16, 2024)Insider Name:Williamson Steven S.Ownership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-2,500Price:$3.57
-
Feb 15, 2024 (filed on Feb 16, 2024)Insider Name:Trigg LeslieOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-5,320Price:$3.57
Filings by filing date
-
Mar 15, 2024 (filed on Mar 15, 2024)Insider Name:Nash MarcOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-2,391Price:$2.13
-
Mar 12, 2024 (filed on Mar 13, 2024)Insider Name:Lang Brent D.Ownership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:108,024Price:--
-
Mar 01, 2024 (filed on Mar 04, 2024)Insider Name:Ahmed NabeelOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-1,584Price:$3.15
-
Feb 29, 2024 (filed on Mar 04, 2024)Insider Name:Ahmed NabeelOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:J - Other transaction# or value acquired/disposed of:1,584Price:$2.68
-
Feb 23, 2024 (filed on Feb 26, 2024)Insider Name:Ahmed NabeelOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-10,639Price:$3.72
-
Feb 23, 2024 (filed on Feb 26, 2024)Insider Name:Ahmed NabeelOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:20,922Price:--
-
Feb 23, 2024 (filed on Feb 26, 2024)Insider Name:Trigg LeslieOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-45,538Price:$3.72
-
Feb 23, 2024 (filed on Feb 26, 2024)Insider Name:Trigg LeslieOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:131,687Price:--
-
Feb 15, 2024 (filed on Feb 16, 2024)Insider Name:Williamson Steven S.Ownership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-2,500Price:$3.57
-
Feb 15, 2024 (filed on Feb 16, 2024)Insider Name:Trigg LeslieOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-5,320Price:$3.57
News
Biz Brief
Sector: Healthcare | Industry: Advanced Medical Equipment & Technology |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 3052 Orchard Drive SAN JOSE CA 95134 |
Tel: | N/A |
Website: | https://outsetmedical.com |
IR: | See website |
Key People | ||
Leslie L. Trigg Chairman of the Board, President, Chief Executive Officer | Nabeel Ahmed Chief Financial Officer | Stacey Porter Chief People Officer |
Jean-Olivier Racine Chief Technology Officer | John L. Brottem General Counsel, Company Secretary |
Business Overview |
Outset Medical, Inc. is a medical technology company. The Company offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. The Company designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by virtually anyone. The Tablo system comprises components, which include Tablo Console, Tablo Cartridge and Tablo Data Ecosystem. Tablo Console is a compact, mobile and versatile machine consisting of an integrated water purification, on-demand dialysate production system and touchscreen interface with 3D animations. It also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform. |
Financial Overview |
For the fiscal year ended 31 December 2023, Outset Medical Inc revenues increased 13% to $130.4M. Net loss increased 6% to $172.8M. Revenues reflect Consumables segment increase of 47% to $42.2M, Services and other revenue segment increase of 22% to $26.8M. Higher net loss reflects Interest expense increase from $3.6M to $12.7M (expense), Research and development increase of 11% to $46.8M (expense). |
Employees: | 480 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $34.33M as of Dec 31, 2023 |
Annual revenue (TTM): | $130.38M as of Dec 31, 2023 |
EBITDA (TTM): | -$163.96M as of Dec 31, 2023 |
Net annual income (TTM): | -$172.80M as of Dec 31, 2023 |
Free cash flow (TTM): | -$134.81M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 51,492,317 as of Mar 6, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |